The US FDA has scheduled a Blood Products Advisory Committee (BPAC) meeting for Thursday to Friday, November 17-18, 2016.
On Thursday morning, the Committee will discuss strategies to manage iron deficiency associated with blood donation. In the afternoon, the Committee will discuss adverse reactions related to blood donation in teenage donors and the effectiveness of several mitigation measures.
On Friday, the Committee will hear an informational session on Zika virus and blood safety in the U.S. Following the informational session, the Committee will hear presentations on the following topics: (1) The Transfusion Transmissible Infections Monitoring System; (2) a summary of the FDA workshop on new methods to predict the immunogenicity of therapeutic coagulation proteins; and (3) a summary of the FDA workshop on preclinical evaluation of red blood cells for transfusion.
See the SAC Tracker report